The WACC of Karyopharm Therapeutics Inc (KPTI) is 6.7%.
| Range | Selected | |
| Cost of equity | 7.60% - 13.50% | 10.55% |
| Tax rate | 0.20% - 0.20% | 0.20% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 4.9% - 8.6% | 6.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.82 | 1.54 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.60% | 13.50% |
| Tax rate | 0.20% | 0.20% |
| Debt/Equity ratio | 3.15 | 3.15 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 4.9% | 8.6% |
| Selected WACC | 6.7% | |